Company / Capital Returned to Shareholders per Share
DaVita Capital Returned to Shareholders per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Returned to Shareholders per Share
$16.25
FY2025
5-year range
$14.99 / $21.68
FY2021-FY2025
Trend
+4.1%
vs FY2024
Sector context
#8 of 108
Health Care
What the data says
Among 108 Health Care companies, DaVita is in the top 7% for capital returned to shareholders per share. Capital Returned to Shareholders per Share has fluctuated over the past 10 years, ranging from $4.20 in FY2017 to $21.68 in FY2021.
Based on SEC 10-K filings.
16.25 in FY2025 with a 5-year CAGR of +12.0%. Top quartile in the Health Care sector.
Declined from $17.02 to $16.25 over the past 2 years.
Health Care sector context is included.
Capital Returned to Shareholders per Share over time
Growth rates
- 3-Year CAGR
- +2.7%
- 5-Year CAGR
- +12.0%
- 10-Year CAGR
- -
Sector benchmark
+228.7% above sector average
Key checks
Key Insights
- In FY2025, capital returned to shareholders per share increased 4.1% year-over-year.
- Ranks #8 out of 108 companies in the Health Care sector.
- Peak capital returned to shareholders per share was recorded in FY2021.
- Lowest capital returned to shareholders per share in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score 1.15 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital Returned to Shareholders per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $16.25 | +4.1% |
| FY2024 | $15.60 | -8.3% |
| FY2023 | $17.02 | +13.5% |
| FY2022 | $14.99 | -30.9% |
| FY2021 | $21.68 | +134.9% |
| FY2020 | $9.23 | +91.3% |
| FY2019 | $4.83 | -19.8% |
| FY2018 | $6.02 | +43.4% |
| FY2017 | $4.20 | -21.7% |
| FY2016 | $5.36 | +110.7% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026